The stem cell leukaemia (SCL) gene: A critical regulator of haemopoietic and vascular development

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 10, 1999, Pages 1193-1207

  Barton, L M ^a   Gottgens B ^a   Green, A R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ONCOPROTEIN;

ANGIOGENESIS; APOPTOSIS; CHROMOSOME TRANSLOCATION; GENE EXPRESSION; GENE LOCUS; HEMATOPOIESIS; HUMAN; LEUKEMOGENESIS; NONHUMAN; REVIEW; STEM CELL; TRANSCRIPTION REGULATION;

EID: 0344980084     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(99)00082-5     Document Type: Article

References (134)

1. Begley C.G., Aplan P.D., Davey M.P., Nakahara K., Tchorz K., Kurtzberg J., Hershfeld M.S., Haynes B.F., Cohen D.I., Waldmann T.A., Kirsch I.R. Chromosomal translocation in a human leukemic stem cell line disrupts the T-cell antigen receptor -chain diversity region and results in a previously unreported fusion transcript. Proc. Natl. Acad. Sci. USA. 86:1989;2031-2035.
2. Chen Q., Cheng J.T., Tsai L.H., Schneider N., Buchanan G., Carroll A., Crist W., Ozanne B., Siciliano M.J., Baer R. The tal gene undergoes chromosome translocation in T-cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J. 9:1990;415-424.
3. Finger L.R., Kagan J., Christopher G., Kurtzberg J., Hershfield M.S., Nowell P.C., Croce C. Involvement of the TCL5 gene on chromosome 1 in T-cell leukemia and melanoma. Proc. Natl. Acad. Sci. USA. 86:1989;5039-5043.
4. Begley C.G., Aplan P.D., Haynes B., Waldmann T.A., Kirsch I.R. A new gene, SCL, is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc. Natl. Acad. Sci. USA. 86:1989;10128-10132.
5. Krause M., Fire A., Harrison S.W., Priess J., Weintraub H. CeMyoD accumulation defines the body wall muscle cell fate during C-elegans embryogenesis. Cell. 63:1990;907-919.
6. Garrell J., Campuzano S. The helix-loop-helix domain: a common motif for bristles, muscles and sex. Bioessays. 13:1991;493-498.
7. Murre C., McCaw P.S., Baltimore D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD and myc proteins. Cell. 56:1989;777-783.
8. Murre C., Bain G., van Dijk M.A., Engel I., Furnari B.A., Massari M.E., Matthews J.R., Quong M.W., Rivera R.R., Stuiver M.H. Structure and function of helix-loop-helix proteins. Biochim. Biophys. Acta. 1218:1994;129-135.
9. Srivastava D., Thomas T., Lin Q., Kirby M.L., Brown D., Olson E.N. Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nat. Genet. 16:1997;154-160.
10. Harfe B.D., Gomes A.V., Kenyon C., Liu J., Krause M., Fire A. Analysis of a Caenorhabditis elegans Twist homolog identifies conserved and divergent aspects of mesodermal patterning. Genes Dev. 12:1998;2623-2635.
11. Dzierzak E., Medvinsky A., de Bruijn M. Qualitative and quantitative aspects of haematopoietic cell development in the mammalian embryo. Immunol. Today. 19:1998;228-236.
12. Bonifer C., Faust N., Geiger H., Muller A.M. Developmental changes in the differentiation capacity of haematopoietic stem cells. Immunol. Today. 19:1998;236-241.
13. Migliaccio G., Migliaccio A.R., Petti S., Mavilio F., Russo G., Lazzaro D., Testa U., Marinucci M., Peschle C. Human embryonic hemopoiesis: kinetics of progenitors and precursors underlying the yolk sac-liver transition. J. Clin. Invest. 78:1986;51-60.
14. Begley C.G., Aplan P.D., Denning S.M., Haynes B., Waldmann T.A., Kirsch I.R. The gene, SCL, is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc. Natl. Acad. Sci. USA. 86:1989;10128-10132.
15. Green A.R., Salvaris E., Begley C.G. Erythroid expression of the "helix-loop-helix" gene, SCL. Oncogene. 6:1991;475-479.
16. Labastie M.C., Cortes F., Romeo P.H., Dulac C., Peault B. Molecular identity of hematopoietic precursor cells emerging in the human embryo. Blood. 92:1998;3624-3635.
17. Green A.R., Visvader J., Lints T., Harvey R., Begley C.G. SCL is coexpressed with GATA-1 in haemopoietic cells but is also expressed in developing brain. Oncogene. 7:1992;653-660.
18. Mouthon M.-A., Bernard O., Mitjavila M-T., Romeo P-H., Vainchenker W., Mathieu-Mahul D. Expression of Tal-1 and GATA-binding proteins during human hematopoiesis. Blood. 81:1993;647-655.
19. Pulford K., Lecointe N., Leroy-Viard K., Jones M., Mathieu-Mahul D., Mason D.Y. Expression of TAL-1 proteins in human tissues. Blood. 85:1995;675-684.
20. Pevny L., Simon M.C., Robertson E., Klein W.H., Tsai S.F., D'Agati V., Orkin S.H., Costantini F. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature. 349:1991;257-260.
21. Fujiwara Y., Browne C.P., Cunniff K., Goff S.C., Orkin S.H. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl. Acad. Sci. USA. 93:1996;12355-12358.
22. Shivdasani R.A., Fujiwara Y., McDevitt M.A., Orkin S.H. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 16:1997;3965-3973.
23. Hwang L.-Y., Siegelman M., Davis L., Oppenheimer-Marks N., Baer R. Expression of the TAL-1 proto-oncogene in cultured endothelial cells and blood vessels of the spleen. Oncogene. 8:1993;3043-3046.
24. Chetty R., Dada M.A., Boshoff C.H., Comley M.A., Biddolph S.C., Schneider J.W., Mason D.Y., Pulford K.A., Gatter K.C. TAL-1 protein expression in vascular lesions. J. Pathol. 181:1997;311-315.
25. Visvader J., Begley C.G., Adams J.M. Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system. Oncogene. 6:1991;195-204.
26. Kallianpur A.R., Jordan J.E., Brandt S.J. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood. 83:1994;1200-1208.
27. Silver L., Palis J. Initiation of murine embryonic erythropoiesis: a spatial analysis. Blood. 89:1997;1154-1164.
28. Elefanty A.G., Begley C.G., Metcalf D., Barnett L., Kontgen F., Robb L. Characterization of hematopoietic progenitor cells that express the transcription factor SCL, using a lacZ 'knock-in' strategy. Proc. Natl. Acad. Sci. USA. 95:1998;11897-11902.
29. Drake C.J., Brandt S.J., Trusk T.C., Little C.D. TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis. Dev. Biol. 192:1997;17-30.
30. A.M. Sinclair, B. Göttgens, L.M. Barton, S. Aparicio, S. Bahn, M.-J. Sanchez, J. Fordham, M.L. Stanley, A.R. Green, Distinct 5′ SCL enhancers direct transcription to developing brain, spinal cord and endothelium; conserved neural expression is GATA factor dependent, Dev. Biol., in press.
31. Turpen J.B., Kelley C.M., Mead P.E., Zon L.I. Bipotential primitive-definitive hematopoietic progenitors in the vertebrate embryo. Immunity. 7:1997;325-334.
32. Mead P.E., Kelley C.M., Hahn P.S., Piedad O., Zon L.I. SCL specifies hematopoietic mesoderm in Xenopus embryos. Development. 125:1998;2611-2620.
33. Gering M., Rodaway A.R.F., Göttgens B., Patient R.K., Green A.R. The SCL gene specifies haemangioblast development from early mesoderm. EMBO J. 17:1998;4029-4045.
34. Liao E.C., Paw B.H., Oates A.C., Pratt S.J., Postlethwait J.H., Zon L.I. SCL/Tal-1 transcription factor acts downstream of cloche to specify hematopoietic and vascular progenitors in zebrafish. Genes Devel. 12:1998;621-626.
35. Aplan P.D., Nakahra K., Orkin S.H., Kirsch I.R. The SCL gene product: a positive regulator of erythroid differentiation. EMBO J. 11:1992;4073-4081.
36. Chiba T., Nagata Y., Kishi A., Sakamaki K., Miyajima A., Yamamoto M., Engel J.D., Todokoro K. Induction of erythroid-specific gene expression in lymphoid cells. Proc. Natl. Acad. Sci. USA. 90:1993;11593-11597.
37. Cross M.A., Heyworth C.M., Murrell A.M., Bockamp E.-O., Cobley U.T., Dexter T.M., Green A.R. Expression of lineage restricted transcription factors precedes lineage specific differentiation in a multipotent haemopoietic progenitor cell line. Oncogene. 9:1994;3013-3016.
38. Condorelli G.L., Tocci A., Botta R., Facchiano F., Testa U., Vitelli L., Valtieri M., Croce C.M., Peschle C. Ectopic TAL-1/SCL expression in phenotypically normal or leukemic myeloid precursors: proliferative and anti-apoptotic effects coupled with a differentiation blockade. Mol. Cell. Biol. 17:1997;2954-2969.
39. Valtieri M., Tocci A., Gabbianelli M., Luchetti L., Masella B., Vitelli L., Botta R., Testa U., Condorelli G.L., Peschle C. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program. Cancer Res. 58:1998;562-569.
40. Elwood N.J., Zogos H., Pereira D.S., Dick J.E., Begley C.G. Enhanced megakaryocyte and erythroid development from normal human CD34(+) cells: consequence of enforced expression of SCL. Blood. 91:1998;3756-3765.
41. Tanigawa T., Elwood N., Metcalf D., Cary D., DeLuca E., Nicola N.A. The SCL gene product is regulated by and differentially regulates cytokine responses during myeloid leukemic cell differentiation. Proc. Natl. Acad. Sci. USA. 90:1993;7864-7868.
42. Hoang T., Paradis E., Brady G., Billia F., Nakahara K., Iscove N.N., Kirsch I.R. Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation. Blood. 87:1996;102-111.
43. Tanigawa T., Nicola N., McArthur G.A., Strasser A., Begley C.G. Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: the effect of enforced expression of the SCL transcription factor. Blood. 85:1995;379-390.
44. Leroy-Viard K., Vinit M.-A., Lecointe N., Jouault H., Hidner U., Romeo P.-H., Mathieu-Mahul D. Loss of TAL-1 protein activity induces premature apoptosis of Jurkat leukemic T-cells upon medium depletion. EMBO J. 14:1995;2341-2349.
45. Bernard M., Delabesse E., Novault S., Hermine O., Macintyre E.A. Antiapoptotic effect of ectopic TAL1/SCL expression in a human leukemic T-cell line. Cancer Res. 58:1998;2680-2687.
46. Robb L., Lyons I., Li R., Hartley L., Kontgen F., Harvey R.P., Metcalf D., Begley C.G. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc. Natl. Acad. Sci. USA. 92:1995;7075-7079.
47. Shivdasani R.A., Mayer E.L., Orkin S.H. Absence of blood formation in mice lacking the T-cell leukemia oncoprotein tal-1/SCL. Nature. 373:1995;432-434.
48. Robb L., Elwood N.J., Elefanty A.G., Köntgen F., Li R., Barnett L.D., Begley C.G. The SCL gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J. 15:1996;4123-4129.
49. Porcher C., Swat W., Rockwell K., Fujiwara Y., Alt F.W., Orkin S.H. The T-cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell. 86:1996;47-57.
50. Elefanty A.G., Robb L., Birner R., Begley C.G. Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells. Blood. 90:1997;1435-1447.
51. Visvader J.E., Fujiwara Y., Orkin S.H. Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Devel. 12:1998;473-479.
52. Weintraub H., Davis R., Tapscott S., Thayer M., Krause M., Benezra R., Blackwell T.K., Turner D., Rupp R., Hollenberg S., Zhuang Y., Lassar A. The myoD gene family: nodal point during specification of the muscle cell lineage. Science. 251:1991;761-766.
53. Lee J.E., Hollenberg S.M., Snider L., Turner D.L., Lipnick N., Weintraub H. Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science. 268:1995;836-844.
54. Goldfarb A.N., Goueli S., Mickelson D., Greenberg J.M. T-cell acute lymphoblastic leukemia: the associated gene SCL/tal codes for a 42-kDa nuclear phosphoprotein. Blood. 58:1992;537-544.
55. Elwood N.J., Green A.R., Melder A., Visvader J., Begley C.G., Nicola N. The SCL protein displays cell-specific heterogeneity in size. Leukemia. 8:1994;106-114.
56. Cheng J.-T., Hsu H.-L., Hwang L.-Y., Baer R. Products of the TAL-1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues. Oncogene. 8:1993;677-683.
57. Cheng J.-T., Cobb M.H., Baer R. Phosphorylation of the TAL-1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1. Mol. Cell. Biol. 13:1993;801-808.
58. Wadman I.A., Hsu H.L., Cobb M.H., Baer R. The MAP kinase phosphorylation site of TAL1 occurs within a transcriptional activation domain. Oncogene. 9:1994;3713-3716.
59. Prasad K.S.S., Brandt S.J. Target-dependent effect of phosphorylation on the DNA binding activity of the TAL1/SCL oncoprotein. J. Biol. Chem. 272:1997;11457-11462.
60. Hsu H.L., Cheng J.T., Chen Q., Baer R. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins. Mol. Cell. Biol. 11:1991;3037-3042.
61. Hsu H.-L., Wadman I., Tsan J.T., Baer R. Positive and negative transcriptional control by the TAL-1 helix-loop-helix protein. Proc. Natl. Acad. Sci. USA. 91:1994;5947-5951.
62. Voronova A.F., Lee F. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation. Proc. Nat. Acad. Sci. USA. 91:1994;5952-5956.
63. Hsu H.-L., Wadman I., Baer R. Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T-cells. Proc. Natl. Acad. Sci. USA. 91:1994;3181-3185.
64. Hsu H.L., Huang L., Tsan J.T., Funk W., Wright W.E., Hu J.S., Kingston R.E., Baer R. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol. Cell. Biol. 14:1994;1256-1265.
65. Nielsen A.L., Norby P.L., Pedersen F.S., Jorgensen P. E-box sequence and context-dependent TAL1/SCL modulation of basic helix-loop-helix protein-mediated transcriptional activation. J. Biol. Chem. 271:1996;31463-31469.
66. Zhao X.F., Aplan P.D. The hematopoietic transcription factor SCL binds the p44 subunit of TFIIH. J. Biol. Chem. 274:1999;1388-1393.
67. Valge-Archer V.E., Osada H., Warren A.J., Forster A., Li J., Baer R., Rabbitts T.H. The LIM proteins RBTN2 and the basic helix-loop-helix protein TAL-1 are present in a complex in erythroid cells. Proc. Natl. Acad. Sci. USA. 91:1994;8617-8621.
68. Osada H., Grutz G., Axelson H., Forster A., Rabbitts T.H. Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1. Proc. Natl. Acad. Sci. USA. 92:1995;9585-9589.
69. Wadman I.A., Osada H., Grutz G.G., Agulnick A.D., Westphal H., Forster A., Rabbitts T.H. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NL1 proteins. EMBO J. 16:1997;3145-3157.
70. Boehm T., Foroni L., Kaneko Y., Perutz M.F., Rabbitts T.H. The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and chromosome 11p13. Proc. Natl. Acad. Sci. USA. 88:1991;4367-4371.
71. Warren A.J., Colledge W.H., Carlton M.B., Evans M.J., Smith A.J., Rabbitts T.H. The oncogenic cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development. Cell. 78:1994;45-57.
72. Yamada Y., Warren A.J., Dobson C., Forster A., Pannell R., Rabbitts T.H. The T-cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc. Natl. Acad. Sci. USA. 95:1998;3890-3895.
73. Rabbitts T.H. Chromosomal translocations in human cancer. Nature. 372:1994;143-149.
74. Larson R.C., Lavenir I., Larson T.A., Baer R., Warren A.J., Wadman I., Nottage K., Rabbitts T.H. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T-cell tumorigenesis in transgenic mice. EMBO J. 15:1996;1021-1027.
75. Agulnick A.D., Taira M., Breen J.J., Tanaka T., Dawid I.B., Westphal H. Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins. Nature. 384:1996;270-272.
76. Mahajan M.A., Park S.T., Sun X.-H. Association of a novel GTP binding protein, DRG, with TAL oncogenic proteins. Oncogene. 12:1996;2343-2350.
77. Zhao X.F., Aplan P.D. SCL binds the human homologue of DRG in vivo. Biochim. Biophys. Acta. 1448:1998;109-114.
78. Cohen-Kaminsky S., Maouche-Chretien L., Vitelli L., Vinit M.A., Blanchard I., Yamamoto M., Peschle C., Romeo P.H. Chromatin immunoselection defines a TAL-1 target gene. EMBO J. 17:1998;5151-5160.
79. Brady G., Billia F., Knox J., Hoang T., Kirsch I.R., Voura E.B., Hawley R.G., Cumming R., Buchwald M., Siminovitch K. Analysis of gene expression in a complex differentiation hierarchy by global amplification of cDNA from single cells. Curr. Biol. 5:1995;909-922.
80. Andre C., d'Auriol L., Lacombe C., Gisselbrecht S., Galibert F. c-kit mRNA expression in human and murine hematopoietic cell lines. Oncogene. 4:1989;1047-1049.
81. Miller B.A., Floros J., Cheung J.Y., Wojchowski D.M., Bell L., Begley C.G., Elwood N.J., Kreider J., Christian C. Steel factor affects SCL expression during normal erythroid-differentiation. Blood. 84:1994;2971-2976.
82. Krosl G., He G., Lefrancois M., Charron F., Romeo P.H., Jolicoeur P., Kirsch I.R., Nemer M., Hoang T. Transcription factor SCL is required for c-kit expression and c-Kit function in hemopoietic cells. J. Exp. Med. 188:1998;439-550.
83. Lecuyer E., Hoang T. SCL mediated transcriptional regulation of the c-kit promoter. Blood. 92:1998;571.
84. Begley C.G., Visvader J., Green A.R., Aplan P.D., Metcalf D., Kirsch I.R., Gough N.M. Molecular cloning and chromosomal localisation of the murine homolog of the human 'helix-loop-helix' gene SCL. Proc. Natl. Acad. Sci. USA. 88:1991;869-873.
85. Aplan P.D., Begley C.G., Bertness V., Nussmeier M.A., Ezquerra A., Coligan J., Kirsch I.R. The SCL gene is formed from a transcriptionally complex locus. Mol. Cell. Biol. 10:1990;6426-6435.
86. Bernard O., Lecointe N., Jonveaux P., Souyri M., Mauchauffe M., Berger R., Larsen C.J., Mathieu-Mahul D. Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5′ part of the tal-1 gene. Oncogene. 6:1991;1477-1488.
87. Bernard O., Azogui O., Lecointe N., Mugneret F., Berger R., Laszenc J., Mathieu-Mahul D. A third tal-1 promoter is specifically used in human T-cell leukaemia. J. Exp. Med. 176:1992;919-925.
88. Begley C.G., Robb L., Rockman S., Visvader J., Bockamp E.-O., Chan Y.S., Green A.R. Structure of the gene encoding the murine SCL protein. Gene. 138:1994;93-99.
89. Baer R. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T-cell acute leukaemia. Semin. Cancer Biol. 4:1993;341-347.
90. Bockamp E.-O., McLaughlin F., Murrell A.M., Göttgens B., Robb L., Begley C.G., Green A.R. Lineage-restricted regulation of the murine SCL/TAL-1 promoter. Blood. 86:1995;1502-1514.
91. Lecointe N., Bernard O., Naert K., Joulin V., Larsen C.J., Romeo P.H., Mathieu-Mahul D. GATA- and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene. Oncogene. 9:1994;2623-2632.
92. Bockamp E.O., McLaughlin F., Göttgens B., Murrell A.M., Elefanty A.G., Green A.R. Distinct mechanisms direct SCL/tal-1 expression in erythroid cells and CD34 positive primitive myeloid cells. J. Biol. Chem. 272:1997;8781-8790.
93. Bockamp E.O., Fordham J.L., Göttgens B., Murrell A.M., Sanchez M.-J., Green A.R. Transcriptional regulation of the stem cell leukemia gene by PU.1 and Elf-1. J. Biol. Chem. 273:1998;29032-29042.
94. Scott E.W., Simon M.C., Anastasi J., Singh H. Requirement of transcription factor PU-1 in the development of multiple hematopoietic lineages. Science. 265:1994;1573-1577.
95. Leroy-Viard K., Vinit M.-A., Lecointe N., Mathieu-Mahul D., Romeo P.-H. Distinct DNase-I hypersensitive sites are associated with TAL-1 transcription in erythroid and T-cell lines. Blood. 84:1994;3619-3827.
96. Göttgens B., McLaughlin F., Bockamp E.O., Fordham J.L., Begley C.G., Kosmopoulos K., Elefanty A.G., Green A.R. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements. Oncogene. 15:1997;2419-2428.
97. J. Fordham, B. Gottgens, F. McLaughlin, A.R. Green, Chromatin structure and transcriptional regulation of the stem cell leukemia (SCL) gene in mast cells, Oncogene, in press.
98. Bash R.O., Hall S., Timmons C.F., Crist W.M., Amylon M., Smith R.G., Baer R. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study. Blood. 86:1995;666-676.
99. Bernard O., Guglielmi P., Jonveaux P., Cherif D., Gisselbrecht S., Mauchauffe M., Berger R., Larsen C.J., Mathieu-Mahul D. Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias. Genes Chromosomes Cancer. 1:1990;194-208.
100. Aplan P.D., Raimondi S.C., Kirsch I.R. Disruption of the SCL gene by a t(1;3) translocation in a patient with T-cell acute lymphoblastic leukemia. J. Exp. Med. 176:1992;1303-1310.
101. Aplan P.D., Johnson B.E., Russell E., Chervinsky D.S., Kirsch I.R. Cloning and characterization of TCTA, a gene located at the site of a t(1;3) translocation. Cancer Res. 55:1995;1917-1921.
102. Xia Y., Brown L., Tsan J.T., Yang C.Y., Siciliano M.J., Crist W.M., Carroll A.J., Baer R. The translocation (1;14)(p34;q11) in human T-cell leukemia: chromosome breakage 25 kilobase pairs downstream of the TAL1 protooncogene. Genes Chromosomes Cancer. 4:1992;211-216.
103. Fitzgerald T.J., Geoffrey A.M., Neale S.C., Raimondi S.C., Goorha R.M. c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-b chain gene by a reciprocal chromosomal translocation: t(1;7) (p32;q35). Blood. 78:1991;2686-2695.
104. Aplan P.D., Lombardi D.P., Ginsberg A.M., Cossman J., Bertness V.L., Kirsch I.R. Disruption of the human SCL locus by 'illegitimate' V-(D)-J recombinase activity. Science. 250:1990;1426-1429.
105. Brown L., Cheng J.T., Chen Q., Siciliano M.J., Crist W., Buchanan G., Baer R. Site-specific recombination of the tal-1 gene is a common occurrence in human T-cell leukemia. EMBO J. 9:1990;3343-3351.
106. Aplan P.D., Lombardi D.P., Kirsch I.R. Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukemia. Mol. Cell. Biol. 11:1991;5462-5469.
107. Collazo-Garcia N., Scherer P., Aplan P.D. Cloning and characterization of a murine SIL gene. Genomics. 30:1995;506-513.
108. Izraeli S., Colaizzo-Anas T., Bertness V.L., Mani K., Aplan P.D., Kirsch I.R. Expression of the SIL gene is correlated with growth induction and cellular proliferation. Cell Growth Differ. 8:1997;1171-1179.
109. Aplan P.D., Lombardi D.P., Reaman G.H., Sather H.N., Hammond G.D., Kirsch I.R. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood. 79:1992;1327-1333.
110. Delabesse E., Bernard M., Landman-Parker J., Davi F., Leboeuf D., Varet B., Valensi F., Macintyre E.A. Simultaneous SIL-TAL1 RT-PCR detection of all tal(d) deletions and identification of novel tal(d) variants. Br. J. Haematol. 99:1997;901-907.
111. Breit T.M., Beishuizen A., Ludwig W.D., Mol E.J., Adriaansen H.J., van Wering E.R., van Dongen J.J. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease. Leukemia. 7:1993;2004-2011.
112. Delabesse E., Bernard M., Meyer V., Smit L., Pulford K., Cayuela J.M., Ritz J., Bourquelot P., Strominger J.L., Valensi F., Macintyre E.A. TAL1 expression does not occur in the majority of T-ALL blasts. Br. J. Haematol. 102:1998;449-457.
113. Macintyre E.A., Smit L., Ritz J., Kirsch I.R., Strominger J.L. Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor alpha beta lineage. Blood. 80:1992;1511-1520.
114. Elwood N.J., Cook W.D., Metcalf D., Begley C.G. SCL, the gene implicated in human T-cell leukaemia, is oncogenic in a murine T-lymphocyte cell line. Oncogene. 8:1993;3093-3101.
115. Robb L., Rasko J.E., Bath M.L., Strasser A., Begley C.G. scl, a gene frequently activated in human T-cell leukaemia, does not induce lymphomas in transgenic mice. Oncogene. 10:1995;205-209.
116. Aplan P.D., Jones C.A., Chervinsky D.S., Zhao X.F., Ellsworth M., Wu C.Z., McGuire E.A., Gross K.W. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice. EMBO J. 16:1997;2408-2419.
117. Condorelli G.L., Facchiano F., Valtieri M., Proietti E., Vitelli L., Lulli V., Huebner K., Peschle C., Croce C.M. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice. Cancer Res. 56:1996;5113-5119.
118. Kelliher M.A., Seldin D.C., Leder P. Tal-1 induces T-cell acute lymphoblastic leukemia accelerated by casein kinase II alpha. EMBO J. 15:1996;5160-5166.
119. Wadman I., Li J., Bash R.O., Forster A., Osada H., Rabbitts T.H., Baer R. Specific in vivo association between the bHLH and LIM proteins implicated in human T-cell leukemia. EMBO J. 13:1994;4831-4839.
120. Ono Y., Fukuhara N., Yoshie O. Transcriptional activity of TAL1 in T-cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL. J. Biol. Chem. 272:1997;4576-4581.
121. Fisch P., Boehm T., Lavenir I., Larson T., Arno J., Forster A., Rabbitts T.H. T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes. Oncogene. 7:1992;2389-2397.
122. Larson R.C., Fisch P., Larson T.A., Lavenir I., Langford T., King G., Rabbitts T.H. T-cell tumours of disparate phenotype in mice transgenic for Rbtn-2. Oncogene. 9:1994;3675-3681.
123. Larson R.C., Osada H., Larson T.A., Lavenir I., Rabbitts T.H. The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice. Oncogene. 11:1995;853-862.
124. Robb L., Begley C.G. The helix-loop-helix gene SCL: implicated in T-cell acute lymphoblastic leukaemia and in normal haematopoietic development. Int. J. Biochem. Cell. Biol. 28:1996;609-618.
125. Grutz G.G., Bucher K., Lavenir I., Larson T., Larson R., Rabbitts T.H. The oncogenic T-cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T-cells. EMBO J. 17:1998;4594-4605.
126. Ono Y., Fukuhara N., Yoshie O. TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3. Mol. Cell. Biol. 18:1998;6939-6950.
127. Greene W.K., Bahn S., Masson N., Rabbitts T.H. The T-cell oncogenic protein HOX11 activates Aldh1 expression in NIH 3T3 cells but represses its expression in mouse spleen development. Mol. Cell. Biol. 18:1998;7030-7037.
128. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
129. Sherr C.J. G1 phase progression: cycling on cue. Cell. 79:1994;551-555.
130. Park S.T., Sun X.H. The Tal1 oncoprotein inhibits E47-mediated transcription: mechanism of inhibition. J. Biol. Chem. 273:1998;7030-7037.
131. Peverali F.A., Ramqvist T., Saffrich R., Pepperkok R., Barone M.V., Philipson L. Regulation of G1 progression by E2A and Id helix-loop-helix proteins. EMBO J. 13:1994;4291-4301.
132. Yan W., Young A.Z., Soares V.C., Kelley R., Benezra R., Zhuang Y. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol. Cell. Biol. 17:1997;7317-7327.
133. Engel I., Murre C. Ectopic expression of E47 or E12 promotes the death of E2A-deficient lymphomas. Proc. Natl. Acad. Sci. USA. 96:1999;996-1001.
134. Johnson S.E., Wang X., Hardy S., Taparowsky E.J., Konieczny S.F. Casein kinase II increases the transcriptional activities of MRF4 and MyoD independently of their direct phosphorylation. Mol. Cell. Biol. 16:1996;1604-1613.